Latest Breaking News On - University hospital vall - Page 8 : comparemela.com

Nesos Announces Peer-Reviewed Validation Of Its First-of-its-Kind Wireless Earbud for the Treatment of Rheumatoid Arthritis February 4, 2021 The study, published in The Lancet Rheumatology, shows promising efficacy and safety profile for Nesos’ novel ‘e-mmunotherapy’ approach to disease treatment REDWOOD CITY, Calif. (February 2, 2021) Nēsos today announced the publication of data from a pilot clinical study demonstrating the power of its e-mmunotherapy platform in the treatment of rheumatoid arthritis. The data, published in The Lancet Rheumatology,  focuses on a clinical study evaluating the Nēsos developed e-mmunotherapy treatment in a cohort of rheumatoid arthritis patients. Patients with moderately to severely active rheumatoid arthritis (RA) despite treatment with conventional synthetic disease-modifying antirheumatic drugs (csDMARD) received daily e-mmunotherapy.

Israel generalUnited statesStanford universitySan diegoComunidad autonoma de catalunaSan franciscoUniversity of californiaFeinstein instituteDivision of immunologyAmerican college of rheumatologyUniversity hospital vallLancet rheumatologyAmerican collegeProfessor sara marsalMatthew bakerMount sinai